Tumor necrosis factor receptor 2, abbreviated TNFR2, is a cell-surface receptor for tumor necrosis factor. In humans the encoding gene is TNFRSF1B; the protein is also known as the p75 receptor or CD120b. It is distinct from the p55 receptor, TNFR1. A cytokine and its receptor are different molecules: one supplies a signal and the other provides a binding and response apparatus.[ref]
The transmembrane protein has an extracellular ligand-binding portion, a membrane-spanning segment and an intracellular portion involved in signal transduction. Binding at the outside and a downstream cellular response are separate experimental observations. A receptor-binding measurement alone does not establish whether a particular cell proliferates, survives or dies.
A motivating molecular experiment used direct expression screening: a human lung-fibroblast cDNA library was screened with radiolabeled tumor necrosis factor alpha. C. A. Smith and colleagues isolated a clone encoding an integral membrane protein of 461 amino acids; the expressed receptor also bound TNF-beta. Its predicted cysteine-rich external region connected it to a broader receptor family.[ref]
A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins by C. A. Smith and others. Abstract, expression library, radiolabeled ligand and predicted extracellular region
This combines a functional binding screen with sequence evidence, rather than identifying a receptor from a name alone.Etanercept provides a useful engineered comparison. It joins the extracellular ligand-binding portion of the human p75 receptor to an Fc region of immunoglobulin G subclass 1, making a soluble dimeric fusion protein.[ref]
Enbrel prescribing information in DailyMed. Sections 11 and 12.1, p75 extracellular region/Fc composition and ligand interception
This retains a ligand-catching surface while omitting the native membrane attachment and intracellular signaling machinery. Its ligand capture therefore does not mean that it reproduces a membrane TNFR2 signal.An experimental comparison can measure binding and cellular response separately, using otherwise matched cells with and without the receptor and controlling for other TNF-binding receptors. A change in labeled-ligand binding tests one part of the mechanism; a change in a specified downstream readout tests another. The receptor's presence alone cannot substitute for either measurement.
Articles by others on the same topic
There are currently no matching articles.